Symptoms of peripheral arterial disease: ramipril

blood pressure 139/85 mmHga 143/80 mmHga Mean maximum walking 239 seconds Not reported time Median maximum walking Not reported 140 metres distance Current smokers 17/40 (42.5%) 16/33 (48.5%) Diabetes mellitus Excluded 11/33 (33%) Hypertension Excluded 20/33 (61%) Medications Aspirin 9/40 (22.5%) Antiplatelet drugs 31/33 (94%) Lipid-lowering drugs 11/40 (27.5%) Lipid-modifying drugs 28/ 33 (85%) Abbreviations: ABPI, ankle brachial pressure index; BMI, body mass index a Information obtained from Shahin et al. (2013b) Table 2 Summary of results for Ahimastos et al. (2006) and Shahin et al. (2013a) Placebo Ramipril Analysis 10 mg Randomised Ahimastos n=20 n=20 et al. (2006) Shahin et n=19 n=14 al. (2013a) Efficacy Ahimastos n=20 n=20 et al. (2006) Shahin et n=17 n=12 al. (2013a)a Primary outcome 1: Ahimastos âˆ’10 seconds 441 seconds Difference change in mean et al. 451 seconds maximum walking (2006) 95% CI 367 seconds to time at 24 weeks 536 seconds p<0.001 Primary outcome 2: Shahin et Not Not Difference 131 m change in mean al. reported reported 95% CI 62 m to 199 m maximum walking (2013a) p=0.001 distance at 24 weeksb Selected secondary outcomes: Change in mean Ahimastos Not Not Difference pain-free walking et al. reported reported 227 seconds time at
